Genentech's sprawling campus overlooking San Francisco Bay seems serene on the surface, but internally, the company resonates with energy.
NIH Study Estimates Pfizer’s Paxlovid Could Reduce COVID-19 Hospitalizations, Saving Billions in Healthcare Costs
Results of a study conducted by the National Institutes of Health indicate that the Paxlovid prevented a substantial number of hospitalizations associated with COVID-19.
Recent Licensing Agreement Poised to Advance Company ADC
In an interview with PharmExec Associate Editor Don Tracy, Jingsong Wang discusses Nona Biosciences’ recent exclusive license agreement with Pfizer Inc. for the development and commercialization of HBM9033.
Frontier Medicines Announces Series C Funding to Advance Development of Next Generation KRAS Blocker
Funds expected to advance multiple programs into clinical studies, including FMC-376, which targets KRASG12C cancers.
Cell and Gene Therapy Check-in 2024
Fran Gregory, VP of Emerging Therapies, Cardinal Health discusses her career, how both CAR-T therapies and personalization have been gaining momentum and what kind of progress we expect to see from them, some of the biggest hurdles facing their section of the industry, the importance of patient advocacy and so much more.
HLTH Inc. and GE Healthcare Reveal Healthcare-Themed Art Gallery
The gallery will be a part of the HLTH Europe event and will be open to all attendees.
WHO Grants Prequalification to Typhoid Vaccine Developed by SK bioscience, International Vaccine Institute
SKYTyphoid showed a positive immunogenicity and safety profile compared to other polysaccharide-protein conjugate typhoid vaccines that obtained prequalification certification by the World Health Organization.
2 Commerce Drive Cranbury, NJ 08512